CPI-RSV-F Vaccine

N/A

Report date: 2024/03/26 17:36:42

Base Information

Drug NameCPI-RSV-F Vaccine
Drug Alias NameBLB-201
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionRespiratory syncytial virus F protein inhibitors
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBlue Lake Biotechnology Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A